Lantern Pharma Inc. Increase (Decrease) in Other Operating Assets
Lantern Pharma Inc. (LTRN) reported Increase (Decrease) in Other Operating Assets of -$10.65 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-14
- Lantern Pharma Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $0.00.
- Lantern Pharma Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$10.65K.
- Lantern Pharma Inc. increase (decrease) in other operating assets for the quarter ending 2024-12-31 was $0.00.
- Lantern Pharma Inc. increase (decrease) in other operating assets for the quarter ending 2024-09-30 was $4.72K.
- Lantern Pharma Inc. increase (decrease) in other operating assets for fiscal 2024 was $10.87K, a 36.20% increase from fiscal 2023.
- Lantern Pharma Inc. increase (decrease) in other operating assets for fiscal 2023 was $7.98K.
- Lantern Pharma Inc. increase (decrease) in other operating assets for fiscal 2021 was -$33.99K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$10.65K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | -$10.65K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $4.72K derived: sum of 2 quarters · filed 2026-03-30 | $10.87K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $4.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $10.87K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $6.15K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | -$7.10K derived: sum of 3 quarters · filed 2025-03-27 | $7.98K 10-K · filed 2025-03-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$7.10K derived: sum of 2 quarters · filed 2024-11-07 | $7.98K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$7.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $7.98K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $15.08K 10-Q · filed 2024-05-09 | |||
| 2021-12-31 | -$51.88K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$51.88K derived: sum of 2 quarters · filed 2023-03-20 | -$33.99K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $17.89K 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $17.89K 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |